The Asia Pacific Cardiac Marker Testing Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).
The measurement of cardiac biomarkers can aid in the diagnosis of a disease. Unlike cardiac imaging, which frequently confirms a diagnosis, simpler and less costly cardiac biomarker measures can inform a physician as to whether more complex or invasive procedures are necessary. In many instances, medical societies encourage physicians to use biomarker measurements as an initial screening method, particularly for patients with a low risk of cardiac mortality.
Numerous acute cardiac marker IVD products are designed for unconventional markets, such as hospital emergency rooms, as opposed to traditional hospital or clinical laboratory settings. Intense competition exists in the development and growth of cardiac marker diagnostic products into new markets. Recently, other potential cardiac markers have been identified as a result of the purposeful loss of myocardial via alcohol septal ablation.
Patients with acute myocardial infarction (MI) and those with SCAD are often distinguished by blood levels of cardiac markers of myocardial necrosis. However, circulating indicators of myocyte injury have recently been identified in patients with SCAD and have been proven to have a graded connection with the later risk for cardiovascular mortality as well as heart failure due to more sensitive cardiac troponin assays.
The considerable senior population in the region is one of the major factors driving the Asia Pacific's market expansion. China's elderly population is ageing faster than the rest of the world. The number of people over 65 increased from 42 million in 1953 to 72 million in 1978. Urban areas experience a faster increase in the elderly population than rural ones. China's elderly population is expected to increase to 11% by the end of the century and 20% by 2025.
The China market dominated the Asia Pacific Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $665.8 million by 2028.The Japan market is estimated to grow a CAGR of 8.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.8% during (2022 - 2028).
Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End User, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cardiac Marker Testing Market is Projected to reach USD 8.1 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Atherosclerosis
- Acute Coronary Syndrome
- Ischemia
By End User
- Laboratory Testing Facilities
- Point-of-Care Testing Facilities
- Academic Institutions
By Product
- Reagents & Kits
- Instruments
By Biomarker Type
- Troponin I & T
- Creatine kinase-MB(CK-MB)
- Natriuretic peptide (Bnp Or Nt-Probnp)
- Myoglobin
- High-sensitivity C-reactive protein(hs-CRP)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG (Siemens AG)
- PerkinElmer, Inc.
- BioMérieux S.A.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- DiaSorin S.p.A.
TABLE 1 Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cardiac Marker Testing Market
TABLE 4 Product Launches And Product Expansions– Cardiac Marker Testing Market
TABLE 5 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 6 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 7 Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 43 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 45 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 46 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 47 Asia Pacific Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 48 Asia Pacific Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 49 China Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 50 China Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 51 China Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 52 China Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 53 China Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 China Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 China Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 56 China Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 57 China Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 58 China Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 59 Japan Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 60 Japan Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 61 Japan Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 62 Japan Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 63 Japan Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 64 Japan Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 65 Japan Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 66 Japan Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 67 Japan Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 68 Japan Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 69 India Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 70 India Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 71 India Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 72 India Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 73 India Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 74 India Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 75 India Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 76 India Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 77 India Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 78 India Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 79 South Korea Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 80 South Korea Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 81 South Korea Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 82 South Korea Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 83 South Korea Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 84 South Korea Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 85 South Korea Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 86 South Korea Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 87 South Korea Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 88 South Korea Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 89 Singapore Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 90 Singapore Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 91 Singapore Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 92 Singapore Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 93 Singapore Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 94 Singapore Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 95 Singapore Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 96 Singapore Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 97 Singapore Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 98 Singapore Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 99 Malaysia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 100 Malaysia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 101 Malaysia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 102 Malaysia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 103 Malaysia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 104 Malaysia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 105 Malaysia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 106 Malaysia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 107 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 108 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 109 Rest of Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 110 Rest of Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 111 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 112 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 113 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 114 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 115 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 116 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 117 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 118 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 119 Key Information – Abbott Laboratories
TABLE 120 Key Information – Siemens Healthineers AG
TABLE 121 Key information – Becton, Dickinson and Company
TABLE 122 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 123 Key Information – Thermo Fisher Scientific, Inc.
TABLE 124 Key Information – Bio-Rad Laboratories, Inc.
TABLE 125 Key Information – Danaher Corporation
TABLE 126 Key Information – DiaSorin S.p.A.
TABLE 127 key Information – PerkinElmer, Inc.
TABLE 128 Key information – BioMérieux S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Siemens Healthineers AG
FIG 7 Swot analysis: Siemens AG
FIG 8 Recent strategies and developments: Thermo Fisher Scientific, Inc.